miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-6
Abstract
We aimed to characterize miR-125b and miR-34a expression in 114 women with different cervical lesions: normal epithelium with (= 20) and without (= 29) HPV infection; LSIL (= 28); HSIL (= 29); and ICC (= 8). miRNA expression analysis was performed by comparing the distinct groups with the reference group (women with normal epithelium without HPV). For miR-125b, we observed a twofold (= 2.11;= 0.038) increased expression among women with normal epithelium with HPV infection and a trend of downregulation in different cervical lesions including an 80% reduction (= 0.21;= 0.004) in ICC. Similarly, miR-34a expression analysis revealed an increased expression (= 1.69;= 0.049) among women with normal cervix and HPV infection, and despite no significant correlation with cervical lesions, its expression was increased by twofold (= 2.08;= 0.042) in ICC. Moreover, miR-125b levels were able to predict invasive cancers with 88% sensitivity and 69% specificity. Results showed that while miR-34a expression seems to be correlated with invasive cervical cancer, miR-125b expression is significantly changed within the different cervical lesions and their levels should be further investigated as possible predictive/prognostic biomarkers using a noninvasive approach.
Keywords
Funding Information
- Portuguese League against Cancer
This publication has 36 references indexed in Scilit:
- Unique microRNA expression profiles in cervical cancer.2013
- Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patientsMemórias do Instituto Oswaldo Cruz, 2012
- MicroRNAs in the p53 network: micromanagement of tumour suppressionNature Reviews Cancer, 2012
- Biomarkers of Cervical Dysplasia and CarcinomaJournal of Oncology, 2011
- Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?Acta Medica Portuguesa, 2011
- Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissuesExperimental & Molecular Medicine, 2011
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) ExpressionJournal of Biological Chemistry, 2010
- Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cellsOncogene, 2007
- Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populationsInternational Journal of Molecular Medicine, 2007
- Viruses in Human CancersScience, 1991